Published in Front Biosci on September 01, 2003
A variant of the SLC10A2 gene encoding the apical sodium-dependent bile acid transporter is a risk factor for gallstone disease. PLoS One (2009) 0.83
Effects of cholesterol on proliferation and functional protein expression in rabbit bile duct fibroblasts. World J Gastroenterol (2004) 0.79
Roles of ApoB-100 gene polymorphisms and the risks of gallstones and gallbladder cancer: a meta-analysis. PLoS One (2013) 0.79
Isolation and biochemical analysis of vesicles from taurohyodeoxycholic acid-infused isolated perfused rat livers. World J Gastroenterol (2013) 0.75
A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet (2007) 2.75
Increased activity of hepatic microsomal triglyceride transfer protein and bile acid synthesis in gallstone disease. Hepatology (2007) 2.05
Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics. Liver Int (2008) 1.71
Ezetimibe prevents cholesterol gallstone formation in mice. Liver Int (2008) 1.62
Phytosterol and cholesterol precursor levels indicate increased cholesterol excretion and biosynthesis in gallstone disease. Hepatology (2012) 1.47
Hypoadiponectinemia and its association with liver fibrosis in morbidly obese patients. Obes Surg (2010) 1.42
Diet as a risk factor for cholesterol gallstone disease. J Am Coll Nutr (2004) 1.25
Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans. J Hepatol (2007) 1.00
Hepatic cholesterol transport from plasma into bile: implications for gallstone disease. Curr Opin Lipidol (2004) 0.96
Cholecystectomy increases hepatic triglyceride content and very-low-density lipoproteins production in mice. Liver Int (2010) 0.94
[Genetic composition of the Chilean population. Analysis of mitochondrial DNA polymorphism]. Rev Med Chil (2002) 0.93
Hepatic overexpression of sterol carrier protein-2 inhibits VLDL production and reciprocally enhances biliary lipid secretion. J Lipid Res (2002) 0.91
Bile acid synthesis is increased in Chilean Hispanics with gallstones and in gallstone high-risk Mapuche Indians. Gastroenterology (2004) 0.84
Genetic evidence that apolipoprotein E4 is not a relevant susceptibility factor for cholelithiasis in two high-risk populations. J Lipid Res (2007) 0.81
Inactivation of hepatic microsomal triglyceride transfer protein protects mice from diet-induced gallstones. Gastroenterology (2006) 0.81
[Natural history of cholelithiasis and incidence of cholecystectomy in an urban and a Mapuche rural area]. Rev Med Chil (2002) 0.81
Insulin and cholesterol gallstones: new insights for a complex pathogenic relationship. Hepatology (2008) 0.80
[Frequency and assessment of symptoms in hospitalized patient with advanced chronic diseases: is there concordance among patients and doctors?]. Rev Med Chil (2008) 0.80
Deficiency of Niemann-Pick C1 protein protects against diet-induced gallstone formation in mice. Liver Int (2010) 0.79
Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease. Ann Hepatol (2011) 0.79
Role of plasma and liver cholesterol- and lipoprotein-metabolism determinants in LpX formation in the mouse. Biochim Biophys Acta (2007) 0.79
Trends in obesity and diabetes prevalence in a Chilean urban population: 1993-2001. Metab Syndr Relat Disord (2008) 0.79
Biliary lipid secretion, bile acid metabolism, and gallstone formation are not impaired in hepatic lipase-deficient mice. Hepatology (2003) 0.78
Cholecystectomy and NAFLD: does gallbladder removal have metabolic consequences? Am J Gastroenterol (2013) 0.78
Fecal bile acid excretion and messenger RNA expression levels of ileal transporters in high risk gallstone patients. Lipids Health Dis (2009) 0.77
[The contribution of Goldstein and Brown to the study of cholesterol metabolism]. Rev Med Chil (2012) 0.77
Apolipoprotein A-I deficiency does not affect biliary lipid secretion and gallstone formation in mice. Liver Int (2010) 0.76
GUTI: a new antigen in the Cromer blood group system. Transfusion (2003) 0.76
Retracted: Advances in the physiological and pathological implications of cholesterol. Biol Rev Camb Philos Soc (2013) 0.76
A new twist in the cholesterol metabolism-based enterohepatic connection. Gastroenterology (2008) 0.75
Incidence and prevalence of hepatitis C virus infection in Chile. Ann Hepatol (2005) 0.75
The ABCs of biliary cholesterol secretion and their implication for gallstone disease. Hepatology (2003) 0.75
Metabolic effects of cholecystectomy: gallbladder ablation increases basal metabolic rate through G-protein coupled bile acid receptor Gpbar1-dependent mechanisms in mice. PLoS One (2015) 0.75
The Amerindian epidemics of cholesterol gallstones: the North and South connection. Hepatology (2003) 0.75
The old enigma of diets, oils, and stones. Nutrition (2005) 0.75
[Self assessment about proficiency on palliative care in a cohort of residents]. Rev Med Chil (2004) 0.75